Medication info
Hasiber Tablet (Acyclovir)

Hasiber Tablet (Acyclovir)

Prescription medicationTabletIntravenous injection
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
Light blue round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201801810 · Approved 2018.04.27 · Insurance code 678600910

Summary

Main use
Treatment and prevention of herpes simplex, treatment of herpes zoster, and treatment of chickenpox in children aged 2 years and older
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. For recurrent infections, it is preferable to start treatment at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg 5 times daily at approximately 4-hour intervals, excluding sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more susceptible to neuropsychiatric adverse reactions; therefore, use caution, for example, by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per administration twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per administration 3 times daily, at approximately 8-hour intervals.
Child administration
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Use the adult dose. 2) Under 2 years of age: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg/kg per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex, treatment of herpes zoster, and treatment of chickenpox in children aged 2 years and older

  • Genital herpes
  • herpes simplex virus infection
  • shingles virus infection
  • acute pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes virus infections that manifest on the skin and mucous membranes, including both primary and recurrent genital herpes. It is also effective in treating shingles virus infections, particularly in relieving acute pain. However, the effects on postherpetic neuralgia have not been clearly proven. This drug is also used to treat chickenpox in children aged 2 years and older. Overall, it is effective in treating and preventing various symptoms caused by viral infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. For recurrent infections, it is preferable to start treatment at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg 5 times daily at approximately 4-hour intervals, excluding sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more susceptible to neuropsychiatric adverse reactions; therefore, use caution, for example, by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per administration twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per administration 3 times daily, at approximately 8-hour intervals.

Child administration

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Use the adult dose. 2) Under 2 years of age: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg/kg per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This medication should not be used by patients who are allergic to this drug or its components, or who have had hypersensitivity reactions to Valaciclovir. Patients with poor renal function should be cautious when using this medication as nervous system side effects may appear more frequently. Patients with impaired liver function should use this medication carefully, as it may worsen liver function. Children and infants require special care when using this drug, and if necessary, it should be used cautiously at the minimum dosage. Elderly patients are more likely to have reduced renal function, potentially leading to higher blood concentrations of this drug. Therefore, careful adjustment of the dosage and administration intervals is necessary. rarely, severe allergic reactions including anaphylactic shock can occur with this medication. If symptoms such as decreased blood pressure, difficulty breathing, or chest tightness occur, immediate discontinuation of the drug and urgent medical treatment are required. Skin reactions such as rashes, fever, blisters, and hives can occur, and if such symptoms develop, the use of the drug should be discontinued. There is a risk of severe skin conditions such as Stevens-Johnson syndrome or toxic epidermal necrolysis, so immediate consultation with a physician is required if skin abnormalities occur. This medication can cause various neurological and psychiatric side effects, including disturbances in consciousness, confusion, hallucinations, seizures, drowsiness, and tremors, particularly in the elderly and those with reduced renal function. If renal function declines, kidney-related abnormalities such as renal failure, hematuria, and proteinuria may occur, so renal status should be checked periodically. This medication can also affect the blood and lymphatic system, leading to changes in white blood cell counts, bleeding, and anemia. Any unusual symptoms should be reported to healthcare personnel. There may be liver-related side effects such as liver dysfunction, jaundice, and hepatitis, so regular liver function tests are advised. Gastrointestinal issues such as gastritis, constipation, nausea, vomiting, and diarrhea may occur, and if these symptoms are severe, consultation with a doctor should follow. Systemic symptoms such as fever, peripheral edema, pallor, fatigue, and headache may occur, so changes in body condition should be carefully monitored. Musculoskeletal symptoms such as myalgia or arthralgia may occur. This medication may also affect the heart and blood vessels, leading to arrhythmias, blood pressure changes, and chest pain, so caution is advised in patients with cardiovascular disease. Urinary issues may arise, such as difficulty urinating or obstructed urination, and any unusual symptoms should be reported. Adequate hydration is crucial when using this medication, especially when dosed at high levels to prevent dehydration. It is most effective to start treatment within 5 days for herpes simplex and chickenpox and within 7 days for shingles, as soon as symptoms appear. Immunocompromised patients may consider intravenous treatment forms. Long-term users of this medication should periodically assess treatment efficacy and side effects. Caution is necessary during potentially hazardous activities such as driving or operating machinery due to possible side effects like disturbances in consciousness or drowsiness. Interactions may occur when used with other medications, especially those affecting the kidneys or certain drugs, increasing the risk of side effects. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and breastfeeding should be discontinued as the drug may pass into breast milk.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reactions
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 118 more
  • urticarial erythema
  • hives
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • agitation
  • ataxia
  • stupor
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • excitement
  • forgetfulness
  • insomnia
  • anxiety
  • talking to oneself
  • sensory disturbances
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glucosuria
  • pneumonia
  • pharyngitis
  • pleurisy
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • low serum protein
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • agitation
  • stupor
  • convulsions
  • drowsiness
  • confusion
  • hallucinations
  • excitation
  • seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture infiltration and kept in a cool, dry place below 25 degrees Celsius. Proper storage can help maintain the drug's efficacy over time.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.